ICAgen Inc. (ICGN) Narrows Q1 Loss
Tweet
Share
E-mailGet Alerts ICGN Hot Sheet
Price: $5.99 --0%
Financial Fact:
Research and development fees: 1.02M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Research and development fees: 1.02M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
ICAgen Inc. (Nasdaq: ICGN) reported Q1 loss of $0.31, versus ($0.54) last year. Revenue for the quarter came in at $1.05 million versus the consensus estimate of $2.6 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
- MeiraGTx Holdings plc (MGTX) Tops Q2 EPS by 202c
- Aebi Schmidt Holding AG (AEBI) Reports Q2 results; offers guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
